Life Sciences Consultancy
About us
Since 2015, Accelero is based in Basel, Switzerland, and supports life science companies raise capital and transform breakthrough science into real-world value.
Our approach is built on three dimensions that guide progress from discovery to impact. You may combine them or select the specific support you require.
Strategic and financial readiness.
Clear strategy. Focused science. A financial foundation will build for what comes next.
Raise capital, partners & licensing opportunities.
Access to investors and collaborators. A value story shaped by scientific depth, clinical direction, and commercial clarity.
Transformation and guide the market path.
Throughout the development process, from preclinical to in-market, we ensure the impact of innovation is sustained.
And we stay with you as you grow. Supporting a transformation that helps biotech organisations scale, adapt, and thrive.
OUR SERVICES
Strategy and Decision Architecture
Translating scientific ambition into strategic direction!
We align research priorities, development milestones, and market potential to design clear, data-driven roadmaps. This will guide decision-making across the pre-clinical, clinical, and growth phases.
Focus
-
Strategic Readiness
-
rNPV & scenario modeling
-
Business model design
-
Commercialisation & exit planning
Commercialisation and Market Access
Turning innovation into patient and market value
As products approach commercialisation, we develop pricing, reimbursement, and evidence strategies that achieve payer confidence and sustainable market access.
Focus
-
Pricing & Reimbursement
-
Health economics & outcomes research
-
Launch planning
-
Revenue forecasting
Investor Access and Licensing
Connecting science with capital, and the right partners!
Beyond introductions to our investor network, we actively support licensing activities by using our pharma contacts to identify, evaluate, and structure collaborations that drive long-term value.
Focus
-
Investment readiness
-
Capital roadmap
-
Investor network introductions
-
Licensing matchmaking
-
Valuation and deal support
Transformation, Integration and Organisational Growth
Building the company behind the science and helping it grow through change.
Our transformation programs prepare leadership teams for scale and guide them through post-merger or organisational change. This will ensure continuity, alignment, and sustainable performance.
Focus
-
Governance & readiness
-
Cultural change
-
M&A integration planning
-
Process guidance & optimisation
-
Scale up management
ACCELERO INSIGHTS
10
Years of Operations
> € 800m
In financial Transactions advised
25+
Partnering & Licensing Transactions
15+
Transformation guided & implemented
Meet Our Team
Detlef Krawinkel
As CEO and Founder Detlef brings over a decade of experience guiding biotech and medtech leaders through critical growth phases. He specializes in strategy, capital access, and board-level advisory.
Dr. Barbara Troup
Barbara is an expert on organizational change and leadership communication. She supports life science companies in navigating transformation with clarity and impact.
Dr. Peter Stagier
Peter combines financial acumen with deep capital raising expertise and forecasting. He advises on cost-effective scale-up and investment planning for life science companies.
Edward Gudaitis
Edward is a seasoned commercial strategist with a track record in biotech and pharma. He guides clients in building competitive go-to-market strategies and securing licensing deals.
Bertrand Bonnot
Bertrand has extensive experience in market entry and international business development. He helps innovators unlock new geographies and build sustainable partnerships.
Ruben Giorgino
Ruben brings extensive experience in pre-clinical & clinical development across pharma and rare diseases. He supports companies in advancing therapies from research through clinical trials, ensuring scientific rigor and regulatory alignment.
Dr. Peter Schiemann
Peter brings decades of experience in product manufacturing and global labeling compliance. He supports companies in delivering reliable, regulatory-compliant products worldwide.
Beat
Widler
Beat is a recognized specialist in regulatory affairs, quality management, and pharmacovigilance. He ensures clients meet compliance standards while accelerating approvals.
CLIENT STORIES
We as a European biotech lacked clarity on strategy, clinical and fundraising. Accelero aligned leadership with a 12-month clinical and commercial roadmap, connected with its investor network, enabling a €20M capital raise and a strategic co-development deal.
CEO Rare Disease Company
Our organisation struggled to secure investors or partners. Accelero reframed our strategy, refined the value proposition, the outreach strategy and while activating its global networks, leading to a $15M Series A Capital Raise.
CEO Cellular Medicine
Our biotech was seeking the right partner. Accelero reshaped the partnering strategy, and leveraged its global network, leading to a global licensing agreement. The deal secured a double-digit million milestone & long-term royalty payments.
CEO Oncology Company
PARTNERSHIPS
Ready to take your innovation from science to scale, and beyond integration? Let us explore how strategy, capital and transformation can accelerate your next phase of growth.